AUD 0.23
(6.98%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | -1641.00 AUD | 99.82% |
2023 | -929.53 Thousand AUD | -315.87% |
2022 | -223.51 Thousand AUD | 71.03% |
2021 | -771.53 Thousand AUD | -81.96% |
2020 | -424.02 Thousand AUD | -110.57% |
2019 | 4.01 Million AUD | 35.14% |
2018 | 2.96 Million AUD | 0.09% |
2017 | 2.96 Million AUD | 19.47% |
2016 | 2.48 Million AUD | 14.79% |
2015 | 2.16 Million AUD | 26.03% |
2014 | 1.71 Million AUD | 15.25% |
2013 | 1.48 Million AUD | 3.36% |
2012 | 1.44 Million AUD | 2.2% |
2011 | 1.41 Million AUD | -1.48% |
2010 | 1.43 Million AUD | -8.36% |
2009 | 1.56 Million AUD | -25.03% |
2008 | 2.08 Million AUD | -49.35% |
2007 | 4.11 Million AUD | -3.56% |
2006 | 4.26 Million AUD | 125.27% |
2005 | 1.89 Million AUD | 1030.28% |
2004 | 167.49 Thousand AUD | 411.05% |
2003 | 32.77 Thousand AUD | -93.81% |
2002 | 529.55 Thousand AUD | 0.0% |
2001 | - AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 FY | -1641.00 AUD | 99.82% |
2024 Q2 | 857.34 Thousand AUD | 0.0% |
2024 Q4 | -1641.00 AUD | 0.0% |
2023 Q4 | -1.13 Million AUD | 0.0% |
2023 FY | -929.53 Thousand AUD | -315.87% |
2023 Q2 | 208.18 Thousand AUD | 0.0% |
2022 FY | -223.51 Thousand AUD | 71.03% |
2022 Q4 | 1721.00 AUD | 0.0% |
2022 Q2 | -192.93 Thousand AUD | 0.0% |
2021 FY | -771.53 Thousand AUD | -81.96% |
2021 Q2 | -463.27 Thousand AUD | 0.0% |
2021 Q4 | -308.25 Thousand AUD | 0.0% |
2020 Q2 | 93.48 Thousand AUD | 0.0% |
2020 FY | -424.02 Thousand AUD | -110.57% |
2020 Q4 | -517.5 Thousand AUD | 0.0% |
2019 FY | 4.01 Million AUD | 35.14% |
2019 Q2 | 2.34 Million AUD | 0.0% |
2019 Q4 | 82.89 Thousand AUD | 0.0% |
2018 Q2 | 1.51 Million AUD | 0.0% |
2018 FY | 2.96 Million AUD | 0.09% |
2018 Q4 | 1.44 Million AUD | 0.0% |
2017 Q4 | 1.48 Million AUD | 0.0% |
2017 Q2 | 1.47 Million AUD | 0.0% |
2017 FY | 2.96 Million AUD | 19.47% |
2016 Q4 | 1.11 Million AUD | 0.0% |
2016 Q2 | 1.36 Million AUD | 0.0% |
2016 FY | 2.48 Million AUD | 14.79% |
2015 FY | 2.16 Million AUD | 26.03% |
2015 Q4 | 1.29 Million AUD | 0.0% |
2015 Q2 | 870.03 Thousand AUD | 0.0% |
2014 Q2 | 958.88 Thousand AUD | 157.5% |
2014 Q1 | 372.39 Thousand AUD | 0.0% |
2014 FY | 1.71 Million AUD | 15.25% |
2014 Q4 | 757.83 Thousand AUD | 0.0% |
2013 Q2 | 866.42 Thousand AUD | 140.48% |
2013 Q3 | 372.39 Thousand AUD | -57.02% |
2013 Q1 | 360.29 Thousand AUD | 0.0% |
2013 Q4 | 372.39 Thousand AUD | 0.0% |
2013 FY | 1.48 Million AUD | 3.36% |
2012 FY | 1.44 Million AUD | 2.2% |
2012 Q4 | 360.29 Thousand AUD | 0.0% |
2012 Q3 | 360.29 Thousand AUD | 0.0% |
2012 Q2 | 360.29 Thousand AUD | 2.2% |
2012 Q1 | 352.54 Thousand AUD | 0.0% |
2011 FY | 1.41 Million AUD | -1.48% |
2011 Q4 | 352.54 Thousand AUD | 0.0% |
2011 Q1 | 357.84 Thousand AUD | 0.0% |
2011 Q2 | 352.54 Thousand AUD | -1.48% |
2011 Q3 | 352.54 Thousand AUD | 0.0% |
2010 Q2 | 357.84 Thousand AUD | -8.36% |
2010 FY | 1.43 Million AUD | -8.36% |
2010 Q1 | 390.47 Thousand AUD | -0.0% |
2010 Q4 | 357.84 Thousand AUD | 0.0% |
2010 Q3 | 357.84 Thousand AUD | 0.0% |
2009 FY | 1.56 Million AUD | -25.03% |
2009 Q1 | 520.85 Thousand AUD | -0.0% |
2009 Q2 | 390.47 Thousand AUD | -25.03% |
2009 Q3 | 390.47 Thousand AUD | -0.0% |
2009 Q4 | 390.47 Thousand AUD | 0.0% |
2008 Q2 | 520.85 Thousand AUD | -15.35% |
2008 Q3 | 520.85 Thousand AUD | -0.0% |
2008 Q4 | 520.85 Thousand AUD | 0.0% |
2008 FY | 2.08 Million AUD | -49.35% |
2008 Q1 | 615.27 Thousand AUD | 0.0% |
2007 Q1 | 1.03 Million AUD | 0.0% |
2007 Q4 | 615.27 Thousand AUD | 0.0% |
2007 Q3 | 615.27 Thousand AUD | 0.0% |
2007 FY | 4.11 Million AUD | -3.56% |
2007 Q2 | 615.27 Thousand AUD | -40.6% |
2006 FY | 4.26 Million AUD | 125.27% |
2006 Q2 | 1.03 Million AUD | 116.29% |
2006 Q3 | 1.03 Million AUD | 0.0% |
2006 Q4 | 1.03 Million AUD | 0.0% |
2006 Q1 | 478.89 Thousand AUD | -0.0% |
2005 Q3 | 478.89 Thousand AUD | -0.0% |
2005 Q2 | 478.89 Thousand AUD | 807.16% |
2005 Q1 | 52.79 Thousand AUD | -0.0% |
2005 Q4 | 478.89 Thousand AUD | 0.0% |
2005 FY | 1.89 Million AUD | 1030.28% |
2004 Q3 | 52.79 Thousand AUD | -0.0% |
2004 Q1 | 68.98 Thousand AUD | 0.0% |
2004 FY | 167.49 Thousand AUD | 411.05% |
2004 Q4 | 52.79 Thousand AUD | 0.0% |
2004 Q2 | 52.79 Thousand AUD | -23.48% |
2003 Q1 | 132.58 Thousand AUD | -0.0% |
2003 FY | 32.77 Thousand AUD | -93.81% |
2003 Q2 | 68.98 Thousand AUD | -47.97% |
2003 Q4 | 68.98 Thousand AUD | -0.0% |
2003 Q3 | 68.98 Thousand AUD | 0.0% |
2002 Q3 | 132.58 Thousand AUD | -0.0% |
2002 FY | 529.55 Thousand AUD | 0.0% |
2002 Q4 | 132.59 Thousand AUD | 0.0% |
2002 Q2 | 132.59 Thousand AUD | 0.0% |
2002 Q1 | - AUD | 0.0% |
2001 Q3 | - AUD | 0.0% |
2001 Q4 | - AUD | 0.0% |
2001 Q2 | - AUD | 0.0% |
2001 FY | - AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
EZZ Life Science Holdings Limited | 50.94 Million AUD | 100.003% |
Anatara Lifesciences Ltd | -748.91 Thousand AUD | 99.781% |
Zelira Therapeutics Limited | 10.28 Thousand AUD | 115.957% |
Biome Australia Limited | 7.66 Million AUD | 100.021% |
Patrys Limited | 1.39 Million AUD | 100.118% |
Orthocell Limited | 3.68 Million AUD | 100.044% |
Imugene Limited | -5.83 Million AUD | 99.972% |
Noxopharm Limited | -534.81 Thousand AUD | 99.693% |
PYC Therapeutics Limited | 22.05 Million AUD | 100.007% |
Chimeric Therapeutics Limited | 7.45 Million AUD | 100.022% |
Prescient Therapeutics Limited | 3.71 Million AUD | 100.044% |
Proteomics International Laboratories Limited | -1.12 Million AUD | 99.854% |
Cynata Therapeutics Limited | 2.31 Million AUD | 100.071% |
CSL Limited | 15.28 Billion AUD | 100.0% |
Arovella Therapeutics Limited | -25.97 Thousand AUD | 93.683% |
Bio-Gene Technology Limited | -301.44 Thousand AUD | 99.456% |
Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 100.002% |
Starpharma Holdings Limited | 7.65 Million AUD | 100.021% |
Nanollose Limited | -348.95 Thousand AUD | 99.53% |
Memphasys Limited | 1606.00 AUD | 202.179% |
Invex Therapeutics Ltd | 1.21 Million AUD | 100.135% |
NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 98.203% |
Amplia Therapeutics Limited | 4.01 Million AUD | 100.041% |
Botanix Pharmaceuticals Limited | -6.55 Million AUD | 99.975% |
Island Pharmaceuticals Limited | 1.25 Million AUD | 100.131% |
Race Oncology Limited | 1.38 Million AUD | 100.118% |
Nyrada Inc. | -5164.07 AUD | 68.223% |
Telix Pharmaceuticals Limited | 308.5 Million AUD | 100.001% |
Dimerix Limited | 583.47 Thousand AUD | 100.281% |
Immutep Limited | 1.44 Million AUD | 100.114% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 100.014% |
Alterity Therapeutics Limited | 3.8 Million AUD | 100.043% |
BTC Health Limited | 16.36 Thousand AUD | 110.031% |
Acrux Limited | -1.28 Million AUD | 99.872% |
Neuren Pharmaceuticals Limited | 205.17 Million AUD | 100.001% |
Biotron Limited | -40.49 Thousand AUD | 95.948% |
Tissue Repair Ltd | 150.51 Thousand AUD | 101.09% |
AdAlta Limited | 1.5 Million AUD | 100.109% |
Radiopharm Theranostics Limited | -21.3 Million AUD | 99.992% |
Hexima Limited | - AUD | Infinity% |
AnteoTech Limited | 460.39 Thousand AUD | 100.356% |
Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 102.888% |
Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 99.553% |
Avecho Biotechnology Limited | -43.79 Thousand AUD | 96.253% |
Actinogen Medical Limited | 9.93 Million AUD | 100.017% |
Immuron Limited | 3.33 Million AUD | 100.049% |
Argenica Therapeutics Limited | 2.59 Million AUD | 100.063% |